TREM2 mcrophage mitigates atherosclerosis by suppressing FTH1/NCOA4-dependent ferroptosis

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Xianglan Liu

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou (China)

4 More presentations in this session

Presentation thumbnail

Chronic cardiac pain fuels atherosclerosis by enhancing the recruitment of inflammatory monocytes

Mr Z. Dong (Nanjing, CN)

Abstract Slides Video

Presentation thumbnail

B Cell TGF-beta1 deficiency prevents VSMC-macrophage phenotype shift and ameliorates advanced atherosclerosis

Doctor K. Miteva (Geneva, CH)

Abstract Slides Video

Presentation thumbnail

Eicosapentaenoic acid (EPA) modulates inflammasome activation in monocyte-derived macrophages isolated from individuals with and without established atherosclerotic cardiovascular disease (ASCVD).

Miss J. Ward (Lincoln, GB)

Abstract Slides Video

Presentation thumbnail

Cigarette smoking upregulates vascular expression of the novel atherosclerosis risk factor ADAMTS-7 via CCL17-CCR4 signaling

Doctor C. Abrahamian (Munich, DE)

Abstract Slides Video

Access the full session

Session thumbnail

Immune regulation and inflammatory drivers of atherosclerosis progression

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Linking risk factors for atherosclerosis development to triggering receptor expressed on myeloid cells 2 - mediated foam cell formation

Congress Presentation

Bidirectional roles of extracellular and intracellular HMGB2 in the development of atherosclerosis

Congress Presentation

Combined administration of atorvastatin and mesenchymal stem cells synergizes to attenuate inflammation and promote efferocytosis in atherosclerotic mice

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources